Resorbable Dextenza is the First Intracanalicular Insert for Drug Delivery

Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug

First Biosimilar For Adults With CD20-Positive, B-Cell Non-Hodgkin’s Lymphoma

Life-Threatening Side Effect of Drug for Acute Myeloid Leukemia

First Drug for Rare Autoimmune Disorder That Affects Nerve, Muscles Connection

Hope For Patients With Highly Aggressive Form of AML

Oncology Therapy for Adult and Pediatric Tumors With a Neurotrophic Receptor Tyrosine Kinase (NTRK) Gene Fusion

First Hedgehog Pathway Inhibitor Approved for AML in Adults Aged 75 and Older

Gene Therapy Granted Regenerative Medicine, Fast Track Designations

More Than 80,000 Injuries Have Been Associated With Medical Devices for Pain Management Since 2008

First and Only Treatment for Rare Hyper-Inflammation Syndrome With High Mortality

First-Line Treatment for People With Life-Threatening Blood Disorder

Lack of Sterility Assurance Cited

Use of Non-Approved Pain Medications Could Cause Dosing Errors, Pump Failures

Combination of Experimental Drug and Checkpoint Inhibitors Fight Tumor Cells

First Once-Daily, Nebulized Bronchodilator Available at End of 2018

AI Software Helps Physicians Prioritize Patients with Hemorrhagic Stroke or Intracranial Trauma

Empagliflozin Could Help Prevent Heart Disease and Heart Failure

Zulresso May Alleviate Symptoms for Thousands of Women

Developed for Tumors Resistant to Other TKIs